Nursing Considerations for Patients With Multiple Myeloma

These 4 interactive videos cover essential topics needed for the optimal nursing management of patients with myeloma and are required for participation in the workshop-style, local live, CE-certified, ONS chapter meetings.
Beth Faiman, PhD, MSN, APRN-BC, AOCN
Sandra E. Kurtin, PhD, ANP-C, AOCN
Patricia Mangan, APRN, BC
Joseph Tariman Headshot
Joseph D. Tariman, PhD, RN, ANP-BC, FAAN

CCO Slidesets

In this downloadable slideset, Patricia Mangan, APRN, BC, reviews the basics of multiple myeloma, including pathogenesis, classification, diagnosis/staging, and natural history as well as treatment strategies and nursing-specific considerations.

Beth Faiman, PhD, MSN, APRN-BC, AOCN Sandra E. Kurtin, PhD, ANP-C, AOCN Patricia Mangan, APRN, BC Joseph Tariman Headshot Joseph D. Tariman, PhD, RN, ANP-BC, FAAN Released: August 20, 2014

In this downloadable slideset, Beth Faiman, APRN-BC, AOCN, reviews nursing considerations for patients receiving induction and maintenance therapy for multiple myeloma, including smoldering myeloma and transplant eligibility.

Beth Faiman, PhD, MSN, APRN-BC, AOCN Sandra E. Kurtin, PhD, ANP-C, AOCN Patricia Mangan, APRN, BC Joseph Tariman Headshot Joseph D. Tariman, PhD, RN, ANP-BC, FAAN Released: August 20, 2014

In this downloadable slideset, Sandra E. Kurtin, RN, MS, discusses supportive care of patients with multiple myeloma, including education of patients and management of disease- and treatment-related adverse events.

Beth Faiman, PhD, MSN, APRN-BC, AOCN Sandra E. Kurtin, PhD, ANP-C, AOCN Patricia Mangan, APRN, BC Joseph Tariman Headshot Joseph D. Tariman, PhD, RN, ANP-BC, FAAN Released: August 21, 2014

In this downloadable slideset, Joseph D. Tariman, PhD, ANP-BC, reviews nursing implications for patients receiving treatment with novel agents for relapsed/refractory myeloma.

Beth Faiman, PhD, MSN, APRN-BC, AOCN Sandra E. Kurtin, PhD, ANP-C, AOCN Patricia Mangan, APRN, BC Joseph Tariman Headshot Joseph D. Tariman, PhD, RN, ANP-BC, FAAN Released: August 21, 2014
Educational grant provided by:
Celgene Corporation
Takeda Oncology
Onyx Pharmaceuticals

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?